Loading clinical trials...
Loading clinical trials...
Detection of Circulating Biomarkers of Immunogenic Cell Death After Radiotherapy and Chemotherapy: An Exploratory Study
Conditions
Interventions
Blood withdrawal
Locations
2
Belgium
Unuversity Hospitals Leuven
Leuven, Belgium
MAASTRO clinic
Maastricht, Netherlands
Start Date
April 4, 2017
Primary Completion Date
June 19, 2019
Completion Date
June 19, 2019
Last Updated
August 21, 2019
NCT06066138
NCT07485114
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
Maastricht Radiation Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions